EPIIOS - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 86797424
Serial Number
86797424
Registration Number
5093926
Word Mark
EPIIOS
Status
700 - Registered
Status Date
2016-12-06
Filing Date
2015-10-23
Registration Number
5093926
Registration Date
2016-12-06
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2016-09-20
Law Office Assigned Location Code
M20
Employee Name
DUBOIS, SUSAN L
Statements
Goods and Services
Active chemical ingredients for use in the manufacture of anti-cancer drugs; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating human diseases of any kind; Chemical additives for use in the manufacture of pharmaceuticals; Chemical preparations for general industrial manufacturing; Chemical preparations, namely, silica based density centrifugation media, to be used in biochemical and clinical research; Chemicals for use in biotechnological product development; Chemicals for use in the biochemical and chemical industry; Chemicals, namely, buffer and standard solutions used in analytical chemistry; Industrial chemicals, namely, crosslinking coagents for thermoplastics; Reagents for use in scientific apparatus for chemical or biological analysis
Goods and Services
Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical solutions used in dialysis; Pharmaceuticals, namely, psychotropics; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient
Goods and Services
Advanced product research in the field of artificial intelligence; Chemical, biochemical, biological and bacteriological research and analysis; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the field of medical physics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Laboratory research services relating to pharmaceuticals; Medical research services in the field of cancer; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Technical research in the field of pharmaceutical studies
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2015-10-28
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-10-28
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2015-10-28
Primary Code
042
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
11 - 1st New Owner Before Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
WEITNAUER RECHTSANW; WEITNAUER RECHTSANW
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2015-10-23014711394EMTrue
2015-10-23014711394EUTrue
Trademark Events
Event DateEvent Description
2015-10-27NEW APPLICATION ENTERED IN TRAM
2015-10-28NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-02-16ASSIGNED TO EXAMINER
2016-02-16NON-FINAL ACTION WRITTEN
2016-02-16NON-FINAL ACTION E-MAILED
2016-02-16NOTIFICATION OF NON-FINAL ACTION E-MAILED
2016-07-19TEAS RESPONSE TO OFFICE ACTION RECEIVED
2016-07-21ASSIGNED TO LIE
2016-07-28CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-07-28TEAS/EMAIL CORRESPONDENCE ENTERED
2016-08-10EXAMINERS AMENDMENT -WRITTEN
2016-08-10EXAMINERS AMENDMENT E-MAILED
2016-08-10NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2016-08-10EXAMINER'S AMENDMENT ENTERED
2016-08-11APPROVED FOR PUB - PRINCIPAL REGISTER
2016-08-18LAW OFFICE PUBLICATION REVIEW COMPLETED
2016-08-24AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2016-08-31NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2016-09-20PUBLISHED FOR OPPOSITION
2016-09-20OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2016-12-06REGISTERED-PRINCIPAL REGISTER
2021-12-06COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED